March 03, 2015 10:18 AM ET

Capital Markets

Company Overview of OrbiMed Advisors, L.L.C.

Company Overview

OrbiMed Advisors, L.L.C. is a private equity and venture capital firm specializing in startups and growth capital investments. It primarily provides its services to pooled investment vehicles. It also caters to investment companies. The firm manages mutual, hedge, royalty and debt funds, venture capital, public and private equity funds for its clients. It primarily invests in the public equity and hedging markets across the globe. The firm primarily invests in healthcare, global health science industry including pharmaceutical, life science, healthcare services, biotechnology, biopharmaceuticals, diagnostics, novel therapies and treatments, health IT, medical device companies, and companies ...

601 Lexington Avenue at 53rd Street

54th Floor

New York, NY 10022-4629

United States

Founded in 1989

Phone:

212-739-6400

Fax:

212-739-6444

Key Executives for OrbiMed Advisors, L.L.C.

Founder, Managing Partner, and Portfolio Manager
Age: 69
Founding General Partner
Age: 63
Founding General Partner, Partner, and Co-Head of Private Equity
Age: 49
Founding General Partner, Founding Partner, and Portfolio Manager
Age: 46
General Partner, Co-Head of Global Private Equity Business, and Chairman
Age: 47
Compensation as of Fiscal Year 2014.

OrbiMed Advisors, L.L.C. Key Developments

OrbiMed Closes Second Healthcare Royalty and Credit Opportunities Fund

OrbiMed reported the closing of its second healthcare royalty and credit opportunities Fund, OrbiMed Royalty Opportunities II, with $924 million in commitments, including $24 million from the General Partner. According to the company, investors in the fund include a broad range of premier endowment, foundation, pension and other institutional investors. Consistent with its predecessor, the new fund will acquire healthcare royalty streams and provide tailored debt capital solutions to healthcare companies and institutions worldwide. The Fund expects to commit between $20 million to $150 million per investment, with the ability to commit larger amounts in collaboration with other OrbiMed funds.

OrbiMed Advisors, L.L.C. Presents at CFOs and COOs Forum, Jan-21-2015 03:10 PM

OrbiMed Advisors, L.L.C. Presents at CFOs and COOs Forum, Jan-21-2015 03:10 PM. Venue: The Plaza Hotel, New York, New York, United States. Speakers: Evan Sotiriou, Chief Financial Officer.

OrbiMed Advisors, L.L.C. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

OrbiMed Advisors, L.L.C. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Similar Private Companies By Industry

Company Name Region
Regions Bank Corporate Trust United States
Platinum Advisory Services United States
Logg Investment Research, Inc. United States
GBS Financial Corp. United States
Mac & Co United States

Recent Private Companies Transactions

Type
Date
Target
Fund Raising
February 2, 2015
OrbiMed Royalty Opportunities Fund II
Private Placement
December 19, 2014
Aduro BioTech, Inc.
Private Placement
December 17, 2014
Pieris Pharmaceuticals, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OrbiMed Advisors, L.L.C., please visit www.orbimed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.